// App-Quantinova.ai

2378 : Responses of AML patients to tailored drug regimens: monitoring cancer subclones by ultra-deep resequencing

Researchers

Presenter

  • Poojitha N Ojamies

Principal Investigators

  • Mika Kontro

  • Henrik Edgren

  • Pekka Ellonen

  • Sonja Lagstrom

  • Henrikki Almusa

  • Timo Miettinen

  • Samuli Eldfors

  • David Tamborero

  • Krister Wennerberg

  • Caroline Heckman

  • Kimmo Porkka

  • Maija Wolf

  • Olli Kallioniemi

Medical Centers

  • Inst. for Molec. Medicine Finland (FIMM), Helsinki, Finland

  • Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

  • MediSapiens Ltd, Helsinki, Finland.

  • Biomedical Genomics Lab, IMIM Hospital del Mar Medical Research Institute, Barcelona, Spain.

Locations

  • Finland

  • Spain

Companies

  • MediSapiens Ltd.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved